BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23672025)

  • 1. [Design, synthesis and cholinesterase inhibitory activity of quinoline-polyamine conjugates].
    Luo W; Huang K; Zhang Z; Hong C; Wang CJ
    Yao Xue Xue Bao; 2013 Feb; 48(2):269-75. PubMed ID: 23672025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
    Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
    Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aromatic-polyamine conjugates as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
    Hong C; Luo W; Yao D; Su YB; Zhang X; Tian RG; Wang CJ
    Bioorg Med Chem; 2014 Jun; 22(12):3213-9. PubMed ID: 24794747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Design, synthesis and evaluation of bis-nicotine derivatives as inhibitors of cholinesterases and beta-amyloid aggregation].
    Luo W; Zhao YM; Tian RG; Su YB; Hong C
    Yao Xue Xue Bao; 2013 Nov; 48(11):1671-6. PubMed ID: 24475704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
    Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK
    Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.
    Najafi Z; Saeedi M; Mahdavi M; Sabourian R; Khanavi M; Tehrani MB; Moghadam FH; Edraki N; Karimpor-Razkenari E; Sharifzadeh M; Foroumadi A; Shafiee A; Akbarzadeh T
    Bioorg Chem; 2016 Aug; 67():84-94. PubMed ID: 27289559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities.
    Luo W; Chen Y; Wang T; Hong C; Chang LP; Chang CC; Yang YC; Xie SQ; Wang CJ
    Bioorg Med Chem; 2016 Feb; 24(4):672-80. PubMed ID: 26752094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
    Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
    Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M; Mohammadi Ziarani G; Lashgari N
    Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
    Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies.
    Shah MS; Najam-Ul-Haq M; Shah HS; Farooq Rizvi SU; Iqbal J
    Comput Biol Chem; 2018 Oct; 76():310-317. PubMed ID: 30142564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
    Huang L; Shi A; He F; Li X
    Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
    Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
    Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
    Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives.
    Saeedi M; Mohtadi-Haghighi D; Mirfazli SS; Mahdavi M; Hariri R; Lotfian H; Edraki N; Iraji A; Firuzi O; Akbarzadeh T
    Chem Biodivers; 2019 Feb; 16(2):e1800433. PubMed ID: 30460743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
    Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
    Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
    Tumiatti V; Milelli A; Minarini A; Rosini M; Bolognesi ML; Micco M; Andrisano V; Bartolini M; Mancini F; Recanatini M; Cavalli A; Melchiorre C
    J Med Chem; 2008 Nov; 51(22):7308-12. PubMed ID: 18954037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling.
    Delogu GL; Matos MJ; Fanti M; Era B; Medda R; Pieroni E; Fais A; Kumar A; Pintus F
    Bioorg Med Chem Lett; 2016 May; 26(9):2308-13. PubMed ID: 26995529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.